Further, inhibition of IL-13–mediated signaling can reverse goblet cell hyperplasia (27, 28), suggesting that IL-13 may contribute to the pathophysiology of airway diseases such as asthma and COPD. Here, IL13 is linked to chronic obstructive pulmonary disease.